Published online before print August 19, 2002, doi: 10.1161/01.CIR.0000032135.98011.C4
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:1189.)
© 2002 American Heart Association, Inc.
Brief Rapid Communications |
C-Reactive Protein Is Associated With Subclinical Epicardial Coronary Calcification in Men and Women
The Framingham Heart Study
From the Framingham Heart Study, Framingham, Mass; Cardiology Division (T.J.W., C.J.O.), Massachusetts General Hospital, Departments of Medicine (D.L., W.J.M.) and Radiology (W.J.M., M.E.C.), Beth Israel-Deaconess Hospital, Harvard Medical School, Boston, Mass; Departments of Medicine and Preventive Medicine and Epidemiology (E.J.B., P.W.F.W.), Boston University School of Medicine, Boston, Mass; Department of Mathematics (R.B.D.), Boston University, Boston, Mass; and the National Heart, Lung, and Blood Institute (D.L., C.J.O.), Bethesda, Md.
Correspondence to Christopher J. O’Donnell, MD, MPH, Framingham Heart Study, 73 Mt Wayte Ave, Framingham, MA 01702. E-mail chris{at}fram.nhlbi.nih.gov
Background— High C-reactive protein (CRP) levels are associated with an increased risk of cardiovascular events, even in apparently healthy individuals. It has not been established whether elevated CRP reflects an increased burden of subclinical coronary atherosclerosis.
Methods and Results— We studied a stratified random sample of 321 men and women (mean age 60 years) from the Framingham Heart Study who were free of clinically apparent cardiovascular disease. Subjects underwent electron-beam computed tomography to assess the number of coronary calcifications and the coronary artery calcification (CAC) Agatston score. Spearman correlation coefficients between CRP and CAC score were calculated and adjusted for age, age plus individual risk factors, and age plus the Framingham coronary heart disease risk score. For both sexes, CRP was significantly correlated with the Agatston score (age-adjusted Spearman correlation: 0.25 for men, 0.26 for women; both P<0.01). After adjustment for age and Framingham risk score, the correlation remained significant (P=0.01) for both sexes. Further adjustment for body mass index attenuated the correlation coefficient for women (0.14, P=0.09) but not for men (0.19, P<0.05).
Conclusions— High CRP levels are associated with increased coronary calcification. Among individuals with elevated CRP, subclinical atherosclerosis may contribute to an increased risk for future cardiovascular events.
Key Words: coronary disease • inflammation • imaging
This article has been cited by other articles:
 |
|
 |
|
  D. D. Sin, S. F. P. Man, D. D. Marciniuk, G. Ford, M. FitzGerald, E. Wong, E. York, R. R. Mainra, W. Ramesh, L. S. Melenka, et al. The Effects of Fluticasone with or without Salmeterol on Systemic Biomarkers of Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1207 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Cassidy-Bushrow, L. F. Bielak, P. F. Sheedy II, S. T. Turner, I. J. Kullo, X. Lin, and P. A. Peyser Coronary Artery Calcification Progression Is Heritable Circulation, July 3, 2007; 116(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. O'Donnell, M. K. Shea, P. A. Price, D. R. Gagnon, P. W. F. Wilson, M. G. Larson, D. P. Kiel, U. Hoffmann, M. Ferencik, M. E. Clouse, et al. Matrix Gla Protein Is Associated With Risk Factors for Atherosclerosis but not With Coronary Artery Calcification Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2769 - 2774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Khera, J. A. de Lemos, R. M. Peshock, H. S. Lo, H. G. Stanek, S. A. Murphy, F. H. Wians Jr, S. M. Grundy, and D. K. McGuire Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study Circulation, January 3, 2006; 113(1): 38 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fuster, Z. A. Fayad, P. R. Moreno, M. Poon, R. Corti, and J. J. Badimon Atherothrombosis and High-Risk Plaque: Part II: Approaches by Noninvasive Computed Tomographic/Magnetic Resonance Imaging J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1209 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kivimaki, D. A. Lawlor, M. Juonala, G. Davey Smith, M. Elovainio, L. Keltikangas-Jarvinen, J. Vahtera, J. S.A. Viikari, and O. T. Raitakari Lifecourse Socioeconomic Position, C-Reactive Protein, and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2197 - 2202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. F Hall Commentary: Use of EBCT in epidemiological studies: the effect of noise and body size on coronary calcium scores Int. J. Epidemiol., February 1, 2005; 34(1): 179 - 180. [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Folsom, G. W. Evans, J. J. Carr, A. E. Stillman, and Atherosclerosis Risk in Communities (ARIC) Study I Association of Traditional and Nontraditional Cardiovascular Risk Factors with Coronary Artery Calcification Angiology, November 1, 2004; 55(6): 613 - 623. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Agmon, B. K. Khandheria, I. Meissner, T. M. Petterson, W. M. O'Fallon, D. O. Wiebers, T. J. H. Christianson, J. P. McConnell, J. P. Whisnant, J. B. Seward, et al. C-Reactive Protein and Atherosclerosis of the Thoracic Aorta: A Population-Based Transesophageal Echocardiographic Study Arch Intern Med, September 13, 2004; 164(16): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. London, C. Marty, S. J. Marchais, A. P. Guerin, F. Metivier, and M.-C. de Vernejoul Arterial Calcifications and Bone Histomorphometry in End-Stage Renal Disease J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1943 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Fruchart, M. C. Nierman, E. S. G. Stroes, J. J. P. Kastelein, and P. Duriez New Risk Factors for Atherosclerosis and Patient Risk Assessment Circulation, June 15, 2004; 109(23_suppl_1): III-15 - III-19. [Abstract] [Full Text]
|
|
|
|
|
|
M. Riediker, W. E. Cascio, T. R. Griggs, M. C. Herbst, P. A. Bromberg, L. Neas, R. W. Williams, and R. B. Devlin Particulate Matter Exposure in Cars Is Associated with Cardiovascular Effects in Healthy Young Men Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 934 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.M. Hirschfield and M.B. Pepys C-reactive protein and cardiovascular disease: new insights from an old molecule QJM, November 1, 2003; 96(11): 793 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Reilly, M. L. Wolfe, A. R. Localio, and D. J. Rader C-Reactive Protein and Coronary Artery Calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA) Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1851 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. London, A. P. Guerin, S. J. Marchais, F. Metivier, B. Pannier, and H. Adda Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1731 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sano, A. Tanaka, M. Namba, Y. Nishibori, Y. Nishida, T. Kawarabayashi, D. Fukuda, K. Shimada, and J. Yoshikawa C-Reactive Protein and Lesion Morphology in Patients With Acute Myocardial Infarction Circulation, July 22, 2003; 108(3): 282 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Aziz, J. L. Fahey, R. Detels, and A. W. Butch Analytical Performance of a Highly Sensitive C-Reactive Protein-Based Immunoassay and the Effects of Laboratory Variables on Levels of Protein in Blood Clin. Vaccine Immunol., July 1, 2003; 10(4): 652 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Blake and P. M. Ridker C-Reactive Protein, Subclinical Atherosclerosis, and Risk of Cardiovascular Events Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1512 - 1513. [Full Text] [PDF]
|
|